<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: The cancerous inhibitor of protein phosphatase 2A (CIP2A) oncoprotein is overexpressed in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> tissue compared to <z:mpath ids='MPATH_458'>normal</z:mpath> colon mucosa </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the impact of CIP2A on <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A tissue microarray consisting of 167 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> specimens was investigated </plain></SENT>
<SENT sid="3" pm="."><plain>The association between CIP2A and clinicopathological parameters was analyzed using the χ(2) test </plain></SENT>
<SENT sid="4" pm="."><plain>Survival was analyzed using the Kaplan-Meier method </plain></SENT>
<SENT sid="5" pm="."><plain>The impact of CIP2A on proliferation and drug resistance was evaluated using the 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium <z:chebi fb="25" ids="15858">bromide</z:chebi> test </plain></SENT>
<SENT sid="6" pm="."><plain>An anchorage-independent colony formation assay was also performed </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: CIP2A was an independent prognostic factor in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> after controlling for other clinical confounding factors, such as stage and lymphovascular invasion, particularly in stages III and IV (hazard ratio = 2.974, P���&lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>The knockdown of CIP2A reduced the proliferation and anchorage-independent colony formation of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells </plain></SENT>
<SENT sid="9" pm="."><plain>Knockdown of CIP2A decreased the resistance of the cells to <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi>, <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>, and SN38 (an active metabolite of irinotecan) </plain></SENT>
<SENT sid="10" pm="."><plain>Treatment with <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi>, <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>, and SN38 decreased CIP2A expression </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: CIP2A is a prognostic factor in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>The knockdown of CIP2A reduced proliferation and anchorage-independent colony formation and increased <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi>, <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>, and SN38 efficacy in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines </plain></SENT>
</text></document>